341 related articles for article (PubMed ID: 33251600)
1. Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus.
Luger T; Augustin M; Lambert J; Paul C; Pincelli C; Torrelo A; Vestergaard C; Wahn U; Werfel T
Pediatr Allergy Immunol; 2021 Apr; 32(3):414-424. PubMed ID: 33251600
[TBL] [Abstract][Full Text] [Related]
2. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.
Luger T; Boguniewicz M; Carr W; Cork M; Deleuran M; Eichenfield L; Eigenmann P; Fölster-Holst R; Gelmetti C; Gollnick H; Hamelmann E; Hebert AA; Muraro A; Oranje AP; Paller AS; Paul C; Puig L; Ring J; Siegfried E; Spergel JM; Stingl G; Taieb A; Torrelo A; Werfel T; Wahn U
Pediatr Allergy Immunol; 2015 Jun; 26(4):306-15. PubMed ID: 25557211
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
7. Position statement: topical calcineurin inhibitors in atopic dermatitis.
Remitz A; De Pità O; Mota A; Serra-Baldrich E; Vakirlis E; Kapp A
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2074-2082. PubMed ID: 30288799
[TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience.
Calzavara-Pinton P; Fabbrocini G; Girolomoni G; Matiucci A; Micali G; Musumeci ML; Patruno C; Pellacani G; Rossi MT; Castello M; Stingeni L
G Ital Dermatol Venereol; 2020 Feb; 155(1):8-13. PubMed ID: 31760730
[TBL] [Abstract][Full Text] [Related]
9. Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective.
Chu CY; Yao TC; Shih IH; Yang CY; Chin CL; Ibrahim SBBK; Thevarajah S; Fon LK; Ho MH; Mo CC; Yu CP; Loo SK; Luger T
Dermatol Ther (Heidelb); 2023 Mar; 13(3):717-727. PubMed ID: 36735214
[TBL] [Abstract][Full Text] [Related]
10. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm.
Luger T; De Raeve L; Gelmetti C; Kakourou T; Katsarou A; Lambert J; Morren MA; Oranje A; Ruer M; Serdaroglu S; Torrelo A; Werfel T
Eur J Dermatol; 2013; 23(6):758-66. PubMed ID: 24185493
[TBL] [Abstract][Full Text] [Related]
12. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
[TBL] [Abstract][Full Text] [Related]
13. Pimecrolimus: a review of its use in atopic dermatitis.
Wellington K; Noble S
Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
[TBL] [Abstract][Full Text] [Related]
14. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
Wellington K; Jarvis B
Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
[TBL] [Abstract][Full Text] [Related]
16. Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis.
Chia BK; Tey HL
Dermatitis; 2015; 26(3):122-32. PubMed ID: 25984688
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
Kalavala M; Dohil MA
Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis.
Devasenapathy N; Chu A; Wong M; Srivastava A; Ceccacci R; Lin C; MacDonald M; Wen A; Steen J; Levine M; Pyne L; Schneider L; Chu DK;
Lancet Child Adolesc Health; 2023 Jan; 7(1):13-25. PubMed ID: 36370744
[TBL] [Abstract][Full Text] [Related]
19. Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis.
Hong CH; Gooderham M; Bissonnette R
J Cutan Med Surg; 2019; 23(4_suppl):5S-10S. PubMed ID: 31476937
[TBL] [Abstract][Full Text] [Related]
20. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
Frankel A; Sohn A; Patel RV; Lebwohl M
J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
